In 2013, the MD Anderson Cancer Center launched a "moon shot" project: diagnose and recommend treatment plans for certain forms of cancer using IBM's Watson cognitive system. But in 2017, the project was put on hold after costs topped $62 million—and the system had yet to be used on patients.
From Harvard Business Review
View Full Article
No entries found